[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.65, "open": 6.44, "dayLow": 6.36, "dayHigh": 6.605, "regularMarketPreviousClose": 6.65, "regularMarketOpen": 6.44, "regularMarketDayLow": 6.36, "regularMarketDayHigh": 6.605, "payoutRatio": 0.0, "beta": 2.696, "trailingPE": 2.3854544, "forwardPE": -41.0, "volume": 5310954, "regularMarketVolume": 5310954, "averageVolume": 8175638, "averageVolume10days": 6130620, "averageDailyVolume10Day": 6130620, "bid": 6.3, "ask": 8.17, "bidSize": 6, "askSize": 2, "marketCap": 1062523200, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 15.22, "priceToSalesTrailing12Months": 0.84665763, "fiftyDayAverage": 6.9634, "twoHundredDayAverage": 7.82785, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 559705408, "profitMargins": 0.38144, "floatShares": 136272124, "sharesOutstanding": 161970000, "sharesShort": 43083264, "sharesShortPriorMonth": 44482397, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.266, "heldPercentInsiders": 0.087799996, "heldPercentInstitutions": 0.5785, "shortRatio": 8.99, "shortPercentOfFloat": 0.26700002, "impliedSharesOutstanding": 161970000, "bookValue": -0.467, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 478696992, "trailingEps": 2.75, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.446, "enterpriseToEbitda": 1.197, "52WeekChange": -0.42355007, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 6.56, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.28571, "targetMedianPrice": 9.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 7, "totalCash": 731478976, "totalCashPerShare": 4.516, "ebitda": 467502016, "totalDebt": 228659008, "quickRatio": 1.783, "currentRatio": 2.056, "totalRevenue": 1254962048, "revenuePerShare": 7.969, "returnOnAssets": 0.1997, "grossProfits": 732558016, "freeCashflow": 61875752, "operatingCashflow": -189210000, "revenueGrowth": 6.103, "grossMargins": 0.58373, "ebitdaMargins": 0.37252, "operatingMargins": 0.77402997, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "regularMarketChangePercent": -1.35339, "regularMarketPrice": 6.56, "marketState": "CLOSED", "postMarketChangePercent": 0.609756, "postMarketPrice": 6.6, "postMarketChange": 0.04, "regularMarketChange": -0.0900002, "regularMarketDayRange": "6.36 - 6.605", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 8175638, "fiftyTwoWeekLowChange": 1.5499997, "corporateActions": [], "postMarketTime": 1754092662, "regularMarketTime": 1754078400, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekLowChangePercent": 0.30938116, "fiftyTwoWeekRange": "5.01 - 15.22", "fiftyTwoWeekHighChange": -8.66, "fiftyTwoWeekHighChangePercent": -0.56898814, "fiftyTwoWeekChangePercent": -42.355007, "dividendDate": 1557446400, "earningsTimestamp": 1754483400, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754483400, "earningsCallTimestampStart": 1754483400, "earningsCallTimestampEnd": 1754483400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.75, "epsForward": -0.16, "epsCurrentYear": 1.59084, "priceEpsCurrentYear": 4.1236076, "fiftyDayAverageChange": -0.40339994, "fiftyDayAverageChangePercent": -0.057931464, "twoHundredDayAverageChange": -1.2678499, "twoHundredDayAverageChangePercent": -0.16196656, "priceToBook": -14.047109, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]